{"id":261026,"date":"2026-06-01T09:17:00","date_gmt":"2026-06-01T13:17:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/06\/01\/medical-care-technologies-otc-pinkmdce-provides-initial-overview-of-melanoma-scan-beta-user-experience-and-interface-design\/"},"modified":"2026-06-01T09:45:19","modified_gmt":"2026-06-01T13:45:19","slug":"medical-care-technologies-otc-pinkmdce-provides-initial-overview-of-melanoma-scan-beta-user-experience-and-interface-design","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/06\/01\/medical-care-technologies-otc-pinkmdce-provides-initial-overview-of-melanoma-scan-beta-user-experience-and-interface-design\/","title":{"rendered":"Medical Care Technologies (OTC PINK:MDCE) Provides Initial Overview of Melanoma Scan Beta User Experience and Interface Design"},"content":{"rendered":"<p><a href=\"https:\/\/www.newswire.com\/news\/medical-care-technologies-otc-pink-mdce-provides-initial-overview-of-melanoma\">Medical Care Technologies (OTC PINK:MDCE) Provides Initial Overview of Melanoma Scan Beta User Experience and Interface Design<\/a><\/p>\n<p><a href=\"https:\/\/www.newswire.com\/news\/medical-care-technologies-otc-pink-mdce-provides-initial-overview-of-melanoma\">https:\/\/www.newswire.com\/news\/medical-care-technologies-otc-pink-mdce-provides-initial-overview-of-melanoma<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-06-01 09:17:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.newswire.com\">www.newswire.com<\/a><\/p>\n<p><strong>Company highlights streamlined body-map tracking and image management features designed to support long-term skin monitoring workflows<\/strong><\/p>\n<p>    <strong class=\"date-line\"><br \/>\n        MESA, Ariz., June 1, 2026 (Newswire.com)<br \/>\n        &#8211;<br \/>\n    <\/strong><strong>Medical Care Technologies Inc. (OTC PINK:MDCE), <\/strong>(&#8220;MDCE&#8221; or the &#8220;Company&#8221;) a technology company focused on AI-powered imaging and wellness applications, today <strong>provided additional details regarding the user experience and interface design objectives currently being incorporated into the MDCE Melanoma Scan Beta platform.<\/strong><\/p>\n<p>Building upon the Company&#8217;s previously disclosed body-map monitoring architecture, current development efforts have increasingly focused on creating a streamlined and intuitive user experience designed to simplify image organization, navigation, and long-term visual tracking workflows.<\/p>\n<p>The Company stated that one of the primary design objectives of the MDCE Melanoma Scan Beta platform is reducing friction associated with image management by providing users with a centralized environment for organizing, reviewing, and comparing historical image records over time.<\/p>\n<p>The platform&#8217;s evolving interface incorporates interactive body-map functionality intended to allow users to visually organize image locations while maintaining access to historical image timelines within a structured monitoring framework. The Company believes intuitive image organization and accessibility are important components of effective longitudinal imaging workflows.<\/p>\n<p>Medical Care Technologies further noted that the platform&#8217;s user experience strategy emphasizes simplicity, consistency, and workflow efficiency. Current development initiatives include navigation refinement, image review optimization, interface responsiveness, and improvements intended to support a seamless user experience across future platform iterations.<\/p>\n<p>&#8220;Our objective is not only to refine sophisticated imaging technologies, but also to ensure those&#8230;<\/p>\n<p><a href=\"https:\/\/www.newswire.com\/news\/medical-care-technologies-otc-pink-mdce-provides-initial-overview-of-melanoma\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medical Care Technologies (OTC PINK:MDCE) Provides Initial Overview of Melanoma Scan Beta User Experience and&#8230;<\/p>\n","protected":false},"author":1,"featured_media":261027,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/cdn.nwe.io\/files\/x\/39\/6e\/e643ed559625c4b38b1ad93eacde.jpg","fifu_image_alt":"","footnotes":""},"categories":[8],"tags":[119],"class_list":["post-261026","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-medical"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/261026"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=261026"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/261026\/revisions"}],"predecessor-version":[{"id":261028,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/261026\/revisions\/261028"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/261027"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=261026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=261026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=261026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}